| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 06/04/2003 | EP0906272B1 Peptides |
| 06/03/2003 | US6573398 Such as (Z)-4-(tert-butylamino)-4-oxo-2-butenoic acid; protective coatings for use as two-part liquid pavement markings |
| 06/03/2003 | US6573295 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 06/03/2003 | US6572881 Delivery of polynucleotides to cells; polylactam |
| 05/30/2003 | WO2002016313A3 Integrin receptor inhibitors |
| 05/29/2003 | US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands |
| 05/29/2003 | US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 05/28/2003 | EP1314719A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 05/28/2003 | EP1313696A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 05/27/2003 | US6569450 Lipid-conjugated polyamide compounds and related compositions and methods thereof |
| 05/22/2003 | WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES |
| 05/22/2003 | WO2002095393A3 Drug evolution: drug design at hot spots |
| 05/22/2003 | WO2002083120A3 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 05/22/2003 | US20030097019 T-butyl cascade polymers |
| 05/22/2003 | US20030097005 Method for the preparation of enantiomerically enriched compounds |
| 05/22/2003 | US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists |
| 05/22/2003 | US20030097002 Enantioselective reactions using two-component chiral phase transfer catalysts in multiphasic systems |
| 05/22/2003 | US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite |
| 05/22/2003 | US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/22/2003 | US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/21/2003 | EP1312611A1 Method of continuously degrading protein |
| 05/21/2003 | EP1311192A1 $g(in vivo) imaging |
| 05/21/2003 | CN1419537A Insecticidal anthranilamides |
| 05/21/2003 | CN1419534A Diphenyl ether compounds useful in therapie |
| 05/21/2003 | CN1419450A Nitrite salts of antimicrobial agents |
| 05/21/2003 | CN1418869A 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
| 05/20/2003 | US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis |
| 05/20/2003 | US6566553 Synthetic pathway relies upon stereospecific synthesis of oxazoline intermediate and stereoselective addition of formyl amide to oxazoline |
| 05/20/2003 | US6566547 Fungicides |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566394 Useful as anti-inflammatory agents and immunosuppressive agents |
| 05/20/2003 | US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric |
| 05/20/2003 | US6565830 DTPA monoamides, pharmaceutical agents containing these compounds, their use and process for their production |
| 05/20/2003 | CA2110693C Amino acid derivative anticonvulsant |
| 05/15/2003 | WO2003040101A1 Anthranilic acid amides and pharmaceutical use thereof |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | WO2002085303A3 Substituted tetracycline compounds for the treatment of malaria |
| 05/15/2003 | WO2002057298A3 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 05/15/2003 | US20030092715 Aryl and biaryl compounds having MCH modulatory activity |
| 05/15/2003 | US20030092634 Novel compounds and compositions as protease inhibitors |
| 05/15/2003 | US20030091551 Tyrosone kinase as insulin receptor; antidiabetic agents |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/14/2003 | EP1310507A2 Novel peptide nucleic acids |
| 05/14/2003 | EP1310482A1 Prodrugs of excitatory amino acids |
| 05/14/2003 | EP1310480A1 Prodrugs of excitatory amino acids |
| 05/14/2003 | EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 05/14/2003 | EP1309552A1 Compounds and inhibitors of phospholipases |
| 05/14/2003 | EP0873330B1 Diarylalkenylamine derivatives |
| 05/14/2003 | CN1418186A Novel crystal of stilbene derivative and process for producing the same |
| 05/13/2003 | US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
| 05/13/2003 | CA2107276C Mineral oil middle distillate compositions |
| 05/08/2003 | WO2003037325A1 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
| 05/08/2003 | US20030087903 Mevinolin derivatives |
| 05/08/2003 | US20030087833 Skin regeneration; antiwrinkle agents, antiaging agents |
| 05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
| 05/08/2003 | CA2465316A1 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 05/07/2003 | EP1308436A1 Calcium receptor antagonists |
| 05/07/2003 | EP1307426A1 Amino diphenyl ethers and amido diphenyl ethers |
| 05/07/2003 | EP1019358B1 3,3-diarylpropylamines , their use and preparation |
| 05/07/2003 | EP0858464B1 Thrombin inhibitors |
| 05/07/2003 | EP0839056B1 Process for producing ioversol |
| 05/07/2003 | CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia |
| 05/07/2003 | CN1415599A Method for synthesizing theanine |
| 05/07/2003 | CN1415596A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science |
| 05/06/2003 | US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides |
| 05/06/2003 | US6559261 A method for producing a polymeric material, said method comprising subjecting a starting material which includes two multiple bonds which are activated so that they will take part in a polymerisation reaction and wherein the multiple bonds |
| 05/06/2003 | US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use |
| 05/02/2003 | EP1305798A2 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305028A2 Antimicrobial biaryl compounds |
| 05/02/2003 | EP1056475B1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors |
| 05/02/2003 | EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
| 05/01/2003 | WO2003035603A1 Acetic acid derivatives |
| 05/01/2003 | WO2003035599A1 Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/01/2003 | WO2003035008A2 Functionalized stilbene derivatives as improved vascular targeting agents |
| 05/01/2003 | WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE |
| 05/01/2003 | WO2002042256A3 N-alkylated gaba compounds, processes for their preparation and their use as medicaments |
| 05/01/2003 | US20030083523 Amide derivatives |
| 05/01/2003 | US20030083519 Glycyl lysine derivatives bound to a central aromatic linking core; angiogenesis inhibitors; antitumor agents; induction of apoptosis; bind to integrin alpha v beta 3 and block its interaction with matrix metalloproteinases |
| 05/01/2003 | US20030083356 Statine derivatives for the treatment of Alzheimer's disease |
| 05/01/2003 | US20030083353 Beta-secretase inhibitors |
| 05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/01/2003 | US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease |
| 05/01/2003 | US20030082831 Apparatus for use in the synthesis of preferential biopolymers |
| 05/01/2003 | US20030082830 Compound for use as diagnostic and therapeutic tools in medicine and science |
| 05/01/2003 | CA2463902A1 Functionalized stilbene derivatives as improved vascular targeting agents |
| 05/01/2003 | CA2463226A1 Acetic acid derivatives |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/29/2003 | US6555580 Treating arteriosclerosis and hypercholesterolaemia |
| 04/29/2003 | US6555570 Growth hormone secretagogous with improved bioavailability |
| 04/29/2003 | US6555562 2-Carboxybenzoyl-(N'-3,5-dichloroisonicotinoyl)-L-4aminophenyl alanine, for example; inhibit the binding of alpha-4 integrins to their ligands, use to treat immune or inflammatory disorders |
| 04/29/2003 | US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 04/24/2003 | WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032893A2 Assignment |
| 04/24/2003 | US20030078355 Tertiary amine methacrylate-based macromonomers and polymers |